Dr. Cibar M. Benitez Farina, MD

Dr. Benitez Farina practices at Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Benitez Farina's NPI, 1538325733, was assigned on August 6, 2008. Dr. Benitez Farina holds New Hampshire license 16940.

Dr. Benitez Farina's primary practice is Henry Ford St. John Hospital, at 22101 Moross Rd, Detroit, MI 48236 in Wayne County. The practice phone is (313) 343-4000.

Dr. Benitez Farina's primary practice is Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Benitez Farina is also affiliated with Henry Ford Hospital. The medical group on file is Henry Ford St. John Hospital. Dmand AI also links Dr. Benitez Farina to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benitez Farina practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Benitez Farina's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Benitez Farina's licenses on file in 2 states: New Hampshire and Michigan.

CMS data shows 883 Medicare services from Dr. Benitez Farina across 10 procedure codes in 2024, for 379 Medicare patients. Medicare paid $77,689 for them.

CMS counts 379 Medicare patients who saw Dr. Benitez Farina in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benitez Farina's median patient age at 76, with 58% women.

In 2024, Dr. Benitez Farina wrote 1,318 Medicare Part D claims for 235 patients. 76% of them were for generic drugs. CMS names the drug for 1,066 of them, across 32 drugs with 11 or more claims each, at $1,713,626 in total drug cost. In 2023, CMS named 850 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Benitez Farina for performance year 2024, reported through an alternative payment model (APM). Dr. Benitez Farina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benitez Farina as offering telehealth.

CMS Open Payments shows 124 general payments to Dr. Benitez Farina from 37 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 68% of the total. Kite Pharma, Inc. paid the most, $12,785.